MedPath

The Effect of Dry Needling in Patients With Knee Osteoarthritis

Not Applicable
Completed
Conditions
Osteoarthritis, Knee
Registration Number
NCT04717167
Lead Sponsor
Universiteit Antwerpen
Brief Summary

Research suggests that myofascial trigger points (MTrP) play an important role in explaining pain in patients with musculoskeletal knee disorders. Trigger points are usually defined as hypersensitive tender spots within taut bands of skeletal muscles that are painful on muscle stimulation and that usually elicit referred pain. Treatment of these trigger points could possibly alleviate symptoms in patients with knee pain. However, literature on the effect of trigger point therapy, dry needling in particular, in patients with musculoskeletal knee disorders is scarce. The purpose of this study is to examine the effect of trigger point therapy (dry needling (DN)) on pain, presence of altered central pain processing, muscle features and gait pattern in patients with knee osteoarthritis (KOA). 60 patients with symptomatic KOA will participate in this study. They will randomly be allocated in either an experimental group (EG) (dry needling technique) or a placebo group (PG) (sham needling technique). Pain (Visual analogue scale (VAS) \& KOA outcome score (KOOS), muscle features during gait and gait pattern (3D gait analysis and surface electroMyoGraphy (EMG)) and presence of altered central pain processing (Central Sensitization Inventory (CSI), Quantitative Sensory testing (QST)) will be measured at baseline and 15 minutes after the intervention. Additionally, pain will be measured 3 days after the intervention. The investigators hypothesize that the effect on the outcome measures will be significantly larger in the EG compared to the PG.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
61
Inclusion Criteria
  • A minimum age of fifty years old;

  • Diagnosed with KOA based on the American College of Rheumatology (ACR) clinical classification criteria(48), including:

    • A Kellgren-Lawrence grade of minimum two on radiography;
    • At least three months of chronical knee pain.
Exclusion Criteria
  • Patients suffering from autoimmune and/or neurological disorders
  • Patients who had a major trauma/fracture of the lower limb in the past six months -
  • Patients who experienced other musculoskeletal problems than OA

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
Pain pressure thresholdsChange from baseline central pain processing at 15minutes postintervention

Measured with an digital algometer (kilogram force/ square cm)

Conditioned pain modulationChange from baseline central pain processing at 15minutes postintervention

Measured with an digital algometer (test stimulus) and an inflatable cuff (conditioning stimulus). (kilogram force/ square cm)

Pain sensationChange from 15minutes postintervention pain sensation at 3days postintervention

Measured with the Knee Osteoarthritis Outcome Score- subscale pain, scored on a scale from 0 to 36, transferred from 0 to 100. Higher scores indicate a higher pain sensation.

Temporal summationChange from baseline central pain processing at 15minutes postintervention

Measured with an digital algometer (kilogram force/ square cm)

Secondary Outcome Measures
NameTimeMethod
Muscle coactivation of musculus Vastus medialis and musculus Biceps femorisChange from baseline muscle coactivation at 15minutes postintervention

Measured with wireless surface electromyography. Muscle activation patterns will be gathered through surface electrodes. Hereafter, the co-contraction index was calculated. Higher percentages indicate higher coactivation.

Muscle coactivation of musculus Tibialis anterior and musculus Gastrocnemius medialisChange from baseline muscle coactivation at 15minutes postintervention

Measured with wireless surface electromyography. Muscle activation patterns will be gathered through surface electrodes. Hereafter, the co-contraction index was calculated. Higher percentages indicate higher coactivation.

Step time (meters/second)Change from baseline muscle coactivation at 15minutes postintervention

measured with force plates and markers to measure toe off and heel strike during a 3D motion analysis.

Muscle coactivation of musculus Vastus medialis and musculus SemitendinosusChange from baseline muscle coactivation at 15minutes postintervention

Measured with wireless surface electromyography. Muscle activation patterns will be gathered through surface electrodes. Hereafter, the co-contraction index was calculated. Higher percentages indicate higher coactivation.

Step width (meters)Change from baseline muscle coactivation at 15minutes postintervention

measured with force plates and markers to measure toe off and heel strike during a 3D motion analysis.

Muscle coactivation of musculus Vastus lateralis and musculus SemitendinosusChange from baseline muscle coactivation at 15minutes postintervention

Measured with wireless surface electromyography. Muscle activation patterns will be gathered through surface electrodes. Hereafter, the co-contraction index was calculated. Higher percentages indicate higher coactivation.

Muscle coactivation of musculus Vastus lateralis and musculus Biceps femorisChange from baseline muscle coactivation at 15minutes postintervention

Measured with wireless surface electromyography. Muscle activation patterns will be gathered through surface electrodes. Hereafter, the co-contraction index was calculated. Higher percentages indicate higher coactivation.

Muscle coactivation of musculus Tibialis anterior and musculus Gastrocnemius lateralisChange from baseline muscle coactivation at 15minutes postintervention

Measured with wireless surface electromyography. Muscle activation patterns will be gathered through surface electrodes. Hereafter, the co-contraction index was calculated. Higher percentages indicate higher coactivation.

Stride time (seconds)Change from baseline muscle coactivation at 15minutes postintervention

measured with force plates and markers to measure toe off and heel strike during a 3D motion analysis.

Stride length (meters)Change from baseline muscle coactivation at 15minutes postintervention

measured with force plates and markers to measure toe off and heel strike during a 3D motion analysis.

Step length (meters)Change from baseline muscle coactivation at 15minutes postintervention

measured with force plates and markers to measure toe off and heel strike during a 3D motion analysis.

Stance phase (%)Change from baseline muscle coactivation at 15minutes postintervention

measured with force plates and markers to measure toe off and heel strike during a 3D motion analysis.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.